Current Research Fellows
Current Research Fellows
We are committed to working together with leading UK universities to identify the next generation of scientific leaders. We fund a number of junior research fellowships across a wide spectrum of translational research fellowships with our partners the Stoneygate Trust across a wide spectrum of translational research projects. Please note that all applications must be made to the host university and not to the Rosetrees Trust.
Chris is a Clinical Fellow under the supervision of Professor Charles Swanton at University College London. He works with patients enrolled in the lung TRACERx (TRAcking lung Cancer Evolution through treatment Rx) study. TRACERx is a multi-centre study tasked with determining the impact of intratumor heterogeneity on clinical outcomes in lung cancer. Chris is focusing on cell free DNA analyses arising from this study and is particularly interested in application of this technology to stratify risk in adjuvant clinical trials.
Alice is currently a Rosetrees/Stoneygate UCL Excellence Fellow. Her research focuses on measuring metabolic heterogeneity in normal tissue (hematopoietic stem cells) and in cancer (leukemia cells), to determine whether distinct cell metabolic states are functionally connected to their potential for malignant transformation and therapy resistance. During her post-doctoral studies at the University of Oxford, Alice resolved stem cell heterogeneity in Chronic Myeloid Leukemia, using a single-cell transcriptomic approach allowing her to characterise a distinct leukemia stem cell population responsible for disease persistence.
Elita is a Rosetrees/Stoneygate Imperial College Research Fellow in bacterial genomic epidemiology and evolution of human pathogens. She is investigating the transmission, evolution and antimicrobial resistance patterns in disease-causing bacteria. Prior to her fellowship, Elita was a postdoctoral research associate at NIHR Health Protection Research Unit (HPRU) at Imperial College London, leading analysis of whole genome sequences of methicillin susceptible Staphylococcus aureus, Escherichia coli, C. difficile, Streptococcus and other bacterial isolates collected from specified populations.
Peter is currently a Rostrees/Stoneygate UCL Excellence fellow combining behavioural, neurophysiological, computational, and virtual reality techniques to study the development of spatial hearing and its maintenance in adulthood. The complementary goals of this research are to provide basic insight into auditory processing and use these insights to improve auditory function in specific environments or populations where it is compromised. Prior to that he completed a DPhil in Physiology as a Newton Abraham scholar in the Oxford Auditory Neuroscience Group, where he also pursued postdoctoral research funded by the Wellcome Trust.
Kerri returned to UCL in 2017 as a Rosetrees UCL Excellence Fellow and an honorary consultant neurologist. Kerri’s research group seeks to understand the underlying pathogenic mechanisms of neurodegenerative disorders, such as Parkinson’s and Alzheimer’s diseases, using the fruit fly Drosophila melanogaster, as well as neuronal models of disease. In particular, her research is focused on unravelling the intracellular trafficking defects in endosomal-lysosomal pathways in Parkinson’s disease.
Nuria is a Rosetrees/Stoneygate Research Fellow based at the Institute for Cell and Molecular Biosciences at Newcastle University where the focus of her lab is understanding the molecular regulation of autophagy during ageing. Prior to that she was a post-doc in the lab of Rajat Singh in New York , where she worked on the correlation between autophagy and nutrient metabolism.
James is currently a Rosetrees/Stoneygate Imperial College Research Fellow based in the Division of Brain Sciences at Imperial College London. His research involves bringing the molecular value of PET to the structural and functional fields of brain networks and connectomics. His background is in biology and molecular neuroscience, gaining a PhD in neuroimaging of the GABA system, and his work in neuroimaging is greatly influenced by identifying physiological relevance.
Barney is an NIHR BRC UCL Excellence Fellow, supported by Rosetrees and Stoneygate Trust funding. In addition, he is also a Motor Neurone Disease (MND) Association Lady Edith Wolfson Senior Non-Clinical Fellow. His research focuses on the development of novel therapeutic strategies to overcome the effects of paralysing conditions, such as MND and neurological injury. Barney employs a combination of cutting-edge techniques, including stem cell based modelling of neuromuscular disease, in vivo neural replacement and “optogenetics” in rodent models of paralysis to artificially restore lost muscle function in response to pulses of light.
Nicola is a Rosetrees/Stoneygate Imperial College Research Fellow based in the National Heart and Lung Institute at Imperial College London. Her research focuses on bioinformatic analysis of large-scale sequencing data sets to investigate the contribution of rare non-coding variants to (cardiovascular) disease. Prior to her fellowship, Nicola was a post-doctoral researcher at the MRC London Institute of Medical Sciences where she developed methods and tools to improve clinical variant interpretation.
Clare is the MQ/Rosetrees fellow and a lecturer in the Department of Behavioural Science and Health at UCL. Clare’s research interest is to understand how genes and the environment impact eating habits.
Dr. Tom Nicholls-Newcastle
Tom is a Rosetrees/Stoneygate Research Fellow based at the Wellcome Centre for Mitochondrial Research at Newcastle University. Tom’s work uses molecular and biochemical techniques to study how the mitochondrial genome is maintained and propagated within human cells, and how the failure of these processes underlies human mitochondrial diseases. Prior to this Fellowship, he worked at the MRC Mitochondrial Biology Unit in Cambridge and then at the University of Gothenburg, Sweden, also studying the genetics of mitochondria and its links to human disease.